Model for estimating dopamine transporter occupancy and subsequent increases in synaptic dopamine using positron emission tomography and carbon-11-labeled cocaine

Biochemical Pharmacology
S J GatleyG J Wang

Abstract

Although increases in dopamine secondary to the inhibition of the dopamine transporter appear to underlie the reinforcing properties of cocaine, there is presently no model that relates the elevation of synaptic dopamine to the transporter occupancy by cocaine. We propose such a model based on positron emission tomographic (PET) measurements of the brain concentration of cocaine and the assumption of rapid equilibrium between free cocaine and cocaine bound to the dopamine transporter. A euphorigenic dose of cocaine (about 40 mg) is predicted to occupy 80-90% of the transporters, while a perceptible dose (about 5 mg) occupies about 40% of the transporters. If reuptake of dopamine is reduced in proportion to the fraction of transporters occupied by cocaine, our model indicates that synaptic dopamine rises supra-linearly with occupancy, so that 5 and 40 mg doses of cocaine give about 2- and 10-fold increases, respectively. A consequence is that a given dose of cocaine produces a similar degree of elevation of dopamine regardless of the prior level of occupation of the transporters by cocaine. This prediction is supported by recent PET/neuropsychological studies in our laboratory where dopamine transporter occupancy was measured af...Continue Reading

References

Jul 1, 1992·Trends in Neurosciences·G R Uhl
Jan 1, 1985·Neuroscience and Biobehavioral Reviews·C A Dackis, M S Gold
Oct 1, 1988·Pharmacology, Biochemistry, and Behavior·L C Nicolaysen, J B Justice
Jan 1, 1995·Life Sciences·A EshlemanM Eldefrawi
Oct 1, 1995·Drug and Alcohol Dependence·S M StineD S Charney
Nov 1, 1995·Psychopharmacology·W A CarlezonR A Wise

❮ Previous
Next ❯

Citations

Sep 2, 1998·Synapse·S L DeweyJ D Brodie
Mar 17, 2010·Psychopharmacology·Marc S BerridgeMark V Boswell
Nov 28, 2007·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Benjamin B GelmanVicki M Soukup
Sep 19, 2003·Current Psychiatry Reports·Kimberly P LindseyNora D Volkow
Dec 21, 2000·Current Psychiatry Reports·P C GottschalkT R Kosten
Dec 7, 2002·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Peter S Talbot, Marc Laruelle
Oct 9, 2007·Nuclear Medicine and Biology·Wynne K SchifferStephen L Dewey
May 6, 2006·Drug and Alcohol Dependence·Dianne E LeeAndrew N Gifford
Jul 10, 1998·Journal of Toxicology. Clinical Toxicology·J S Fowler, N D Volkow
Mar 10, 2015·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Scot McIntoshScott E Hemby
Mar 21, 2003·Journal of Substance Abuse Treatment·David A SmelsonDouglas Ziedonis
Dec 13, 2016·ACS Chemical Neuroscience·Zachary D BrodnikRodrigo A España
Jan 30, 2015·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jason R RichardsonGary W Miller
Apr 10, 2018·ACS Chemical Neuroscience·Lindsey R Drake, Peter J H Scott

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.